Financial Performance - The company's operating revenue for the reporting period reached ¥539,732,616.19, representing a year-on-year increase of 12.92%[4] - The net profit attributable to shareholders decreased by 71.51% to ¥6,430,753.38 compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 84.92% to ¥2,206,078.86[4] - Basic earnings per share decreased by 72.41% to ¥0.08[4] Assets and Equity - Total assets at the end of the reporting period amounted to ¥997,831,415.35, an increase of 4.60% from the beginning of the period[4] - Shareholders' equity attributable to the company decreased by 1.84% to ¥547,604,293.22[4] Operational Challenges - The decline in net profit was primarily due to the suspension of a 10,000 tons/year tetrahydrofuran production line and planned upgrades to a 300 tons/year catalyst production line, leading to an asset impairment provision of approximately ¥27 million[5] - The increase in operating revenue was attributed to improved production management and increased output of fine chemical products[5] Dividends and Share Repurchases - Cash dividends paid during the reporting period amounted to ¥8,213,000, and share repurchases totaled ¥10,975,900[5] Cautionary Note - The company emphasizes that the financial data is preliminary and unaudited, urging investors to be cautious[6]
美邦科技(832471) - 2024 Q4 - 年度业绩